Live Breaking News & Updates on Indian covishield

Stay informed with the latest breaking news from Indian covishield on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Indian covishield and stay connected to the pulse of your community

'Myriad' Dermatologic Reactions After COVID-19 Vaccination

COVID-19 vaccination can cause a host of both acute and delayed dermatologic reactions, say Indian researchers, who urge a thorough assessment in every affected patient to demonstrate causality.

Glasgow , Glasgow-city , United-kingdom , United-states , Bikaner , Rajasthan , India , British , Indian-covishield , Alpana-mohta , Saleem-taibjee , Medscape-coronavirus-resource-center

Serum Institute plans manufacturing plant in Africa in global expansion

Africa was the only continent that did not have its own manufacturing capacity for COVID shots during the worst phases of the pandemic in the last two years, leaving it at the mercy of suppliers from overseas, including the SII.

Rwanda , South-africa , India , Indian-covishield , Adar-poonawalla , Astrazeneca , World-health-organization , World-economic-forum-in-davos , Serum-institute-of-india , Serum-institute , Executive-adar-poonawalla , World-economic-forum

'Never been a better time to be vaccine manufacturer': Serum Institute planning to set up its 1st plant in Africa | India News

Asked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so infectious", Reuters reported.

Rwanda , South-africa , India , Russia , Indian-covishield , Adar-poonawalla , Astrazeneca , World-health-organization , World-economic-forum-in-davos , Serum-institute-of-india , Serum-institute , Executive-adar-poonawalla

Indian vaccine giant Serum plans African plant in global expansion

By Aditya Kalra DAVOS, Switzerland (Reuters) - The Serum Institute of India (SII), the world's biggest vaccine maker, is considering setting up its fi...

Rwanda , South-africa , Davos , Switzerland-general- , Switzerland , India , Krishnan-das , Aditya-kalra , Mark-potter , Indian-covishield , Adar-poonawalla , Astrazeneca

Indian vaccine giant Serum plans African plant in global expansion

By Aditya Kalra DAVOS, Switzerland (Reuters) - The Serum Institute of India (SII), the world's biggest vaccine maker, is considering setting up its fi...

Rwanda , South-africa , Davos , Switzerland-general- , Switzerland , India , Krishnan-das , Aditya-kalra , Mark-potter , Indian-covishield , Adar-poonawalla , Astrazeneca

Indian vaccine giant Serum plans African plant in global expansion

DAVOS, Switzerland (Reuters) - The Serum Institute of India (SII), the world's biggest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling COVID-19 shots, its CEO told Reuters on Monday.

Rwanda , South-africa , Davos , Switzerland-general- , Switzerland , India , Krishnan-das , Aditya-kalra , Mark-potter , Indian-covishield , Adar-poonawalla , Astrazeneca

Travellers with the Chinese Sinovac and Indian Covishield vaccines won't need to hotel quarantine

This significant move will boost the university sector by allowing international students from China and India to re-enter the country.

China , Australia , Mumbai , Maharashtra , India , Singapore , Aussies , Australian , Australians , Scott-morrison , Indian-covishield , Greg-hunt